Martini, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 11.233
EU - Europa 9.836
AS - Asia 7.350
SA - Sud America 1.674
AF - Africa 228
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 16
Totale 30.360
Nazione #
US - Stati Uniti d'America 10.967
SG - Singapore 3.531
DE - Germania 3.454
CN - Cina 2.017
SE - Svezia 1.572
BR - Brasile 1.392
IT - Italia 940
PL - Polonia 877
UA - Ucraina 694
FR - Francia 496
GB - Regno Unito 434
IE - Irlanda 415
VN - Vietnam 378
FI - Finlandia 355
IN - India 331
ID - Indonesia 265
RU - Federazione Russa 205
TR - Turchia 154
AR - Argentina 124
CA - Canada 119
HK - Hong Kong 117
JP - Giappone 102
MX - Messico 95
BD - Bangladesh 86
IQ - Iraq 71
AT - Austria 66
BE - Belgio 65
ZA - Sudafrica 61
NL - Olanda 59
CI - Costa d'Avorio 54
ES - Italia 49
EC - Ecuador 40
VE - Venezuela 38
IR - Iran 30
KR - Corea 28
PK - Pakistan 27
CH - Svizzera 26
LT - Lituania 25
KE - Kenya 24
SA - Arabia Saudita 23
PY - Paraguay 19
CO - Colombia 18
CZ - Repubblica Ceca 18
IL - Israele 17
UZ - Uzbekistan 17
JO - Giordania 16
MA - Marocco 16
AE - Emirati Arabi Uniti 15
TN - Tunisia 15
NP - Nepal 14
AZ - Azerbaigian 13
EU - Europa 13
PE - Perù 13
CL - Cile 12
JM - Giamaica 12
RO - Romania 12
AU - Australia 11
EG - Egitto 11
GR - Grecia 11
OM - Oman 10
PH - Filippine 10
SN - Senegal 10
DZ - Algeria 9
KG - Kirghizistan 9
KZ - Kazakistan 9
AL - Albania 8
BO - Bolivia 8
CR - Costa Rica 8
UY - Uruguay 8
BG - Bulgaria 7
ET - Etiopia 7
GE - Georgia 7
LB - Libano 7
LV - Lettonia 7
NO - Norvegia 7
BH - Bahrain 6
MD - Moldavia 6
PA - Panama 6
PT - Portogallo 6
HU - Ungheria 5
KW - Kuwait 5
NI - Nicaragua 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
XK - ???statistics.table.value.countryCode.XK??? 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DO - Repubblica Dominicana 4
GA - Gabon 4
LK - Sri Lanka 4
AM - Armenia 3
BW - Botswana 3
DK - Danimarca 3
EE - Estonia 3
LU - Lussemburgo 3
NG - Nigeria 3
TH - Thailandia 3
AO - Angola 2
BB - Barbados 2
GT - Guatemala 2
Totale 30.312
Città #
Singapore 1.789
Chandler 1.618
Ashburn 1.532
Warsaw 839
Beijing 425
Jacksonville 421
Dublin 408
San Jose 405
San Mateo 342
Nanjing 311
Fairfield 306
Wilmington 290
Ann Arbor 285
Woodbridge 280
Houston 276
Los Angeles 271
New York 270
Munich 245
Jakarta 241
Seattle 230
Nürnberg 218
Dearborn 190
Helsinki 177
Boston 170
Cattolica 165
Rome 155
Ho Chi Minh City 131
Redmond 131
Lawrence 130
São Paulo 130
Dallas 128
Milan 127
Frankfurt am Main 118
Izmir 118
Nanchang 112
The Dalles 112
Moscow 110
Hong Kong 109
Bremen 105
Cambridge 103
Hefei 101
Hanoi 95
Marseille 93
Princeton 91
Chicago 88
Buffalo 77
Redwood City 76
Hyderabad 75
Tokyo 72
Santa Clara 71
Kunming 68
Brussels 59
London 57
Abidjan 54
Mountain View 52
Lancaster 49
Tianjin 49
Norwalk 48
Shenyang 48
Rio de Janeiro 45
Boardman 44
Guangzhou 44
Hebei 42
Orem 42
Phoenix 42
Vienna 41
Zhengzhou 40
Brooklyn 38
Changsha 37
Denver 37
Montreal 37
Jiaxing 36
Johannesburg 36
Hangzhou 35
Shanghai 35
Stockholm 35
Chennai 34
University Park 34
Düsseldorf 33
Belo Horizonte 32
Toronto 32
Leawood 31
Paris 30
Falls Church 29
Lauterbourg 29
Atlanta 28
Poplar 28
Augusta 27
Jinan 26
Kraków 26
Seoul 25
Baghdad 24
Kent 24
Naples 23
Porto Alegre 23
Brasília 22
Fremont 22
Pune 22
Amsterdam 21
Dhaka 21
Totale 16.158
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 599
Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas 392
Deregulated expression of the imprinted DLK1-DIO3 region in Glioblastoma Stem-like Cells: tumor suppressor role of lncRNA MEG3 355
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes 350
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome 328
Fanconi anemia gene variants in therapy-related myeloid neoplasms 304
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma 297
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 297
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 294
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes with Different Clinical Outcome 285
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor 278
Role of p16/INK4a in gastrointestinal stromal tumor progression 275
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 266
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 263
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 255
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 242
Glioblastoma endothelium drives bevacizumab-induced infiltrative growth via modulation of PLXDC1 236
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 221
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 206
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 195
Von hippel-lindau disease and erythrocytosis 195
A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy. 195
Defective WNT Signaling and Genetic Profile Of Endothelial Cells In Patients With Low Risk Myelodysplastic Syndromes Suggest a Contribution Of Vascular Niches To Myelodysplasia 194
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 189
Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients 182
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 178
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience 178
Endothelial progenitor cells in HIV-positive patients: what are we talking about? 173
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 172
Endoscopic ultrasound-guided fine-needle aspiration with liquid-based cytologic preparation in the diagnosis of primary pancreatic lymphoma 169
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 169
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 168
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 168
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 168
PDGFRA-mutant syndrome 168
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 160
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 159
Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients 158
A Large Series of Hyalinizing Trabecular Tumors: Cytomorphology and Ancillary Techniques on Fine Needle Aspiration 158
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 158
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 155
Endoscopic ultrasound-guided fine-needle aspiration with liquid-based cytologic preparation in the diagnosis of primary pancreatic lymphoma 154
Diagnostic and prognostic value of immunocytochemistry and braf mutation analysis on liquid based biopsies of thyroid neoplasms suspicious for carcinoma. 154
Soft tissue non-Hodgkin lymphoma of shoulder in a HIV patient: a report of a case and review of the literature 153
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 152
Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia 152
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 151
Brain invasion along perivascular spaces by glioma cells: Relationship with blood–brain barrier 151
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 151
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 148
The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience 147
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 146
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 145
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 145
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 145
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 145
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 145
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 144
Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review 144
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 142
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 142
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 141
Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model 141
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 140
Difference in clonality as a tool for differential diagnosis of primary versus secondary lung neoplasms. 139
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 138
Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people 138
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 138
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 138
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 137
Hu/elav RNA-binding protein HuR regulates parathyroid hormone related peptide expression in human lung adenocarcinoma cells 137
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia 136
Endoscopic ultrasound-guided fine needle tissue acquisition biopsy samples do not allow a reliable proliferation assessment of gastrointestinal stromal tumours 135
Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model. 133
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 132
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 131
Short Communication: Proangiogenic Hematopoietic Cells In Acute HIV Infection 131
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 130
The role of fine-needle aspiration in the thyroid nodules of elderly patients. 129
An abnormal secretion of soluble mediators contributes to the hematopoietic-niche dysfunction in low-risk myelodysplastic syndrome 128
Digital slides as an effective tool for programmed death ligand 1 combined positive score assessment and training: Lessons learned from the 'Programmed death ligand 1 key learning program in Head-and-Neck squamous cell carcinoma' 126
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 125
Clinical and prognostic features of lymphomas arising in the head and neck region: Our experience of preferential association of different histotypes with various sites of origin in ninety patients 124
Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification 124
Unusual focal keratin expression in plexiform angiomyxoid myofibroblastic tumor: A case report and review of the literature 123
Targeting the mitogen-activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low-grade glioma cells 123
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 123
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases 122
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 122
CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence 122
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 122
Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: A detailed clinical, pathologic, and molecular characterization 122
The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms 121
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 121
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 120
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 120
Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens 120
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 120
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 120
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma 119
Totale 17.519
Categoria #
all - tutte 122.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.459


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.014 0 0 0 0 0 0 216 39 240 120 347 52
2021/20222.128 192 164 55 174 158 79 47 327 111 140 307 374
2022/20234.514 623 649 360 712 252 543 219 349 505 57 151 94
2023/20242.435 89 591 57 130 64 247 395 287 38 77 231 229
2024/20254.256 111 124 362 182 325 172 187 183 627 438 828 717
2025/20267.589 1.671 343 661 1.343 2.122 600 849 0 0 0 0 0
Totale 30.653